# US Coronary Angiography Devices Market > US Coronary Angiography Devices Market Research Report By Product Type (Angiography Catheters, Contrast Media, Angiography Systems, Inflatable Balloons, Guidewires), By Application (Coronary Angiography, Peripheral Angiography, Neuro Angiography, Interventional Angiography), By End-user (Hospitals, Ambulatory Surgical Centers, Diagnostic Imaging Centers, Specialty Clinics), and By Technology (Digital Angiography, Computed Tomography Angiography, Magnetic Resonance Angiography) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 11.42% - **2024:** $ 2,871.64 Million - **2025:** $ 3,199.59 Million - **2035:** $ 9,436.18 Million - **Key Players:** Abbott (US), Boston Scientific (US), Medtronic (US), Siemens Healthineers (DE), Philips (NL), GE Healthcare (US), Cardinal Health (US), Terumo (JP), B. Braun (DE) **Report ID:** MRFR/HC/54969-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-coronary-angiography-devices-market-56735 --- ## Market Summary ## **US Coronary Angiography Devices Market Overview** As per MRFR analysis, the US Coronary Angiography Devices Market Size was estimated at 3.91 (USD Billion) in 2023. The US Coronary Angiography Devices Market is expected to grow from 4.5 (USD Billion) in 2024 to 7.5 (USD Billion) by 2035. The US Coronary Angiography Devices Market CAGR (growth rate) is expected to be around 4.753% during the forecast period (2025 - 2035). ## **Key US Coronary Angiography Devices Market Trends Highlighted** The rising incidence of cardiovascular illnesses, a serious public health problem, is propelling the US market. The need for angiography operations has increased due to an aging population and a rise in lifestyle-related illnesses. Healthcare providers are forced to invest in sophisticated diagnostic tools. This opens new avenues for innovation and device development. Furthermore, the field of cardiovascular diagnostics is evolving due to new technology. This includes robotic-assisted systems and 3D imaging. These developments are increasing patient outcomes and experience. They also enhance operation safety and accuracy. More chances for the use of coronary angiography equipment have been created by telemedicine's growth. This is in response to the COVID-19 epidemic, which also simplified patient cardiac care. Minimally invasive procedures are gaining popularity, according to recent trends. They are linked to fewer problems and quicker recovery periods. This change is forcing manufacturers to enhance product lineups. They also look into joint ventures with healthcare institutions to better meet patient needs. Additionally, US regulatory agencies are expediting medical device approval procedures. This facilitates the launch of new goods by innovators. These trends point to a dynamic and quickly changing environment in the US market. This offers a plethora of opportunities for expansion and advancement. ### Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review ## **US Coronary Angiography Devices Market Drivers** ### **Rising Incidence of Cardiovascular Diseases** The US [Coronary Angiography Devices Market](../../../reports/coronary-angiography-devices-market-6151) is experiencing significant growth. This is due to the increasing prevalence of cardiovascular diseases. According to the American Heart Association, approximately 697,000 Americans died from heart disease in 2020. This highlights a continued upward trend in heart-related health issues. The Centers for Disease Control and Prevention (CDC) estimates that about 18.2 million adults aged 20 and older have coronary artery disease. This drives the demand for coronary angiography procedures. Major healthcare organizations, such as the American College of Cardiology, support R&D. This includes novel angiography devices, enhancing market growth. With an aging population, more diagnostic and therapeutic procedures will be needed. This will subsequently boost angiography device sales significantly. ### **Technological Advancements in Angiography Devices** Innovations in technology have played a crucial role in advancing the US Coronary Angiography Devices Market. The market is witnessing the introduction of state-of-the-art imaging technologies. This includes 3D angiography and hybrid systems that enhance visualization during procedures. Companies like Siemens Healthineers and GE Healthcare are actively investing in R&D. This aims to improve device efficacy and patient safety. According to the Food and Drug Administration (FDA), approval of advanced angiography tools has doubled. This has occurred in the last five years, enabling more effective diagnosis and treatment. This surge in technological advancement not only enhances procedural accuracy. It also promotes the adoption of angiography devices in hospitals and clinics. ### **Increasing Approval of New Devices** The US Coronary Angiography Devices Market is benefiting from increasing new device approvals. These are by regulatory authorities such as the Food and Drug Administration (FDA). In recent years, there has been a notable rise in coronary device approval. The FDA has cleared more than 15 new angiographic products in the past year alone. This surge supports the growing demand for innovative devices in clinical practice. Leading medical device companies, such as Abbott Laboratories and Boston Scientific, are driving this trend. They focus on research initiatives aimed at expanding their product portfolios. The result is an influx of advanced devices that provide improved outcomes for patients. This ultimately fuels market growth. ### **Government Initiatives and Funding** Government initiatives and funding targeting cardiovascular health are vital drivers for market expansion. The National Institutes of Health (NIH) allocates a significant budget portion towards cardiovascular disease research. This is approximately $500 million annually. These funds support studies exploring the efficacy of various angiography technologies. They also support their application in clinical scenarios. Additionally, policies aimed at improving healthcare access, like the Affordable Care Act, have facilitated wider availability. This includes angiographic procedures. Organizations like the American College of Cardiology advocate for legislative efforts. These efforts promote better cardiovascular care, allowing patients to benefit from cutting-edge technologies. Collectively, these initiatives help bolster market growth while enhancing patient outcomes. ## **US Coronary Angiography Devices Market Segment Insights** ### **Coronary Angiography Devices Market Product Type Insights** The US Coronary Angiography Devices Market is characterized by its diverse Product Type segmentation. This plays a crucial role in the overall functioning and effectiveness of cardiovascular interventions. Among these, Angiography Catheters are vital as they facilitate blood vessel navigation. This enables imaging and treatment of various cardiovascular diseases. This category significantly contributes to healthcare providers' diagnostic capabilities. It allows precise localization of arterial blockages. Conversely, Contrast Media is critical for enhancing visibility of internal structures during angiography. This ensures clarity in imaging results. The continuous advancement in this segment reflects ongoing innovation. This innovation aims at improving patient safety and diagnostic accuracy. In addition, Angiography Systems represent a fundamental market component. They incorporate cutting-edge technology to provide real-time imaging. Demand for these systems is increasingly driven by the rise in cardiovascular diseases. Also, the need for effective intervention technologies across hospitals and clinical settings in the US. Inflatable Balloons play a significant role in angioplasty procedures. They help in dilating narrowed arteries, restoring blood flow and improving patient outcomes. The importance of this segment cannot be understated. It often serves as the first line of treatment in cardiac care. Guidewires also hold a significant position. They aid in the precision of catheter placements and ensure efficient navigation. This is through the vascular system. The utility of Guidewires in improving procedural success rates positions them as a crucial element. This is in the overall coronary intervention process. As these products evolve with technological advancements, they contribute to more effective treatments. They also contribute to better patient management. Each of these Product Types contributes uniquely to the market landscape. They collectively facilitate the growth and improvement of cardiac care in the nation. Market trends indicate an increasing emphasis on innovation and patient-centered solutions within these segments. This signals numerous opportunities for market players to explore new avenues for growth and development. ### Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review ### **Coronary Angiography Devices Market Application Insights** The US Coronary Angiography Devices Market demonstrates substantial growth potential. This is particularly within various applications, including Coronary Angiography, Peripheral Angiography, Neuro Angiography, and Interventional Angiography. Coronary Angiography remains a cornerstone for diagnosing heart diseases. It plays a crucial role in guiding treatments for coronary artery disease. Meanwhile, Peripheral Angiography emphasizes access to limb circulation. It addresses conditions such as peripheral artery disease. Neuro Angiography is vital for evaluating cerebrovascular diseases. This is critical for early identification and treatment of strokes. Interventional Angiography focuses on minimally invasive procedures. It enhances patient recovery rates and reduces hospital stays. This aligns with current trends toward outpatient care. These applications collectively fuel market growth. Health initiatives in the US encourage early diagnosis and treatment of cardiovascular conditions. This drives demand for advanced devices and technologies within this space. The US Coronary Angiography Devices Market segmentation highlights unique requirements. It also highlights innovations across these fields. Ultimately, it shapes effective healthcare solutions tailored to diverse patient populations. ### **Coronary Angiography Devices Market End-user Insights** The End-user segment of the US Coronary Angiography Devices Market plays a crucial role. This is in the overall landscape of cardiac health. It reflects progressive advancements in medical technology and procedural efficiency. Hospitals typically demand a substantial share of these devices. This is due to their extensive cardiac care services and critical emergency interventions. Ambulatory Surgical Centers have gained significance. They offer specialized outpatient services, minimizing patient recovery times. They also address the growing trend towards minimally invasive procedures. Diagnostic Imaging Centers facilitate early detection and management of cardiovascular diseases. This enhances patient outcomes and drives device utilization. Specialty Clinics have also become increasingly important. They focus on tailored patient care. This promotes the adoption of advanced angiography devices to meet specific treatment needs. Each of these End-user categories contributes uniquely to the market. Reinforcing innovations that cater to varying patient demographics and clinical requirements. The combination of enhanced healthcare infrastructure and growing awareness of heart disease management. This further drives engagement across these sectors. This emphasizes the U.S.'s commitment to improving cardiovascular health. ### **Coronary Angiography Devices Market Technology Insights** The US Coronary Angiography Devices Market showcases a diverse Technology landscape. This primarily encompasses Digital Angiography, Computed Tomography Angiography, and Magnetic Resonance Angiography. Digital Angiography plays a pivotal role in enhancing imaging clarity and accuracy. It effectively facilitates real-time visualization of vascular structures. This is crucial for timely diagnosis and intervention. Computed Tomography Angiography has gained prominence. This is due to its non-invasive nature and ability to provide comprehensive 3D vascular images. This makes it significant in assessing coronary diseases efficiently. Meanwhile, Magnetic Resonance Angiography offers an excellent alternative. This is for patients with allergies to contrast agents. This addresses safety concerns associated with traditional imaging methods. The integration of advanced imaging technologies within these segments is driven by rising demand. This demand is for minimally invasive diagnostic procedures. Furthermore, an increase in cardiovascular diseases necessitates enhanced diagnostic accuracy and efficiency. This propels innovation and development within the US Coronary Angiography Devices Market. Each technology segment contributes uniquely to the overall landscape. This demonstrates significant improvements in patient outcomes and operational efficiency. This is across healthcare facilities in the US. ## **US Coronary Angiography Devices Market Key Players and Competitive Insights** The US Coronary Angiography Devices Market is characterized by a dynamic competitive landscape. Innovation and technological advancement play pivotal roles in driving growth. Companies operating within this market focus on developing sophisticated devices. These devices enhance the quality of coronary imaging and improve patient outcomes. The market is shaped by factors such as regulatory standards, reimbursement policies. Advancements in minimally invasive procedures also play a role. As coronary artery diseases continue to be a leading health concern, demand remains robust. Competition is intensified by the presence of established manufacturers and emerging players. All strive to secure their market position through strategic partnerships. Product launches and enhanced distribution networks are also utilized. Abbott has carved a significant niche within the US Coronary Angiography Devices Market. It leverages its strong reputation for quality and innovation. The company is known for its advanced imaging solutions. These cater to a wide array of healthcare needs. Abbott's strengths lie in its comprehensive portfolio. This includes cutting-edge technologies that facilitate effective diagnosis and treatment. This is for cardiovascular diseases. The company’s strong focus on research and development enables it to stay ahead of industry trends. This ensures it meets healthcare providers' evolving demands. Additionally, Abbott has established a robust distribution network that enhances its market reach. This solidifies its reputation as a trusted leader in the coronary devices sector. Philips is another key player within the US Coronary Angiography Devices Market. It is distinguished for its commitment to healthcare innovation and integrated solutions. The company's presence in this market is backed by its extensive range of diagnostic imaging systems. Notably, its advanced angiography systems provide high-quality imaging while optimizing workflows. Philips has strategically invested in developing digital solutions. These enable seamless integration of data across various healthcare platforms. This approach enhances collaboration among healthcare professionals and improves patient management. The company benefits from a strong market presence due to strategic mergers and acquisitions. These have expanded its technological capabilities and service offerings. With continued investment in research and development, Philips aims to advance its product portfolio. This maintains its competitive edge in the ever-evolving landscape of coronary angiography devices. ### **Key Companies in the US Coronary Angiography Devices Market Include** - Abbott - Philips - Boston Scientific - Medtronic - Stryker - Zeus Battery Products - Terumo - Cardinal Health - Covidien - AngioDynamics - MediClear - Johnson & Johnson - Braun - [Siemens Healthineers](https://www.siemens-healthineers.com/en-in/angio) - GE Healthcare ### **US Coronary Angiography Devices Market Developments** Recent developments in the US Coronary Angiography Devices Market highlight significant growth and innovation. Abbott has launched new imaging technologies, enhancing procedural safety and effectiveness. Philips is advancing its integration of AI in cardiovascular imaging solutions. This allows for improved patient outcomes. Medtronic is focusing on expanding its product portfolio. This is particularly in catheter-based intervention devices. Boston Scientific is investing in clinical studies to validate efficacy of its latest offerings. In terms of mergers and acquisitions, Terumo acquired Merit Medical Systems in August 2023. This strengthened its presence in the US market. Additionally, GE Healthcare announced its acquisition of a medical data analytics firm in May 2023. This aimed to bolster its technological capabilities in cardiac imaging. The market is witnessing an uptick in investment. This is particularly in Research and Development initiatives. Leading companies like Johnson and Johnson and Stryker are increasing their allocation to drive innovation. Overall, the US Coronary Angiography Devices Market is evolving rapidly. This is driven by technological advancements, strategic partnerships, and ongoing emphasis. This emphasis is on enhancing patient care through improved diagnostic and treatment solutions. ## **Coronary Angiography Devices Market Segmentation Insights** ### **Coronary Angiography Devices Market Product Type Outlook** - Angiography Catheters - Contrast Media - Angiography Systems - Inflatable Balloons - Guidewires ### **Coronary Angiography Devices Market Application Outlook** - Coronary Angiography - Peripheral Angiography - Neuro Angiography - Interventional Angiography ### **Coronary Angiography Devices Market End-user Outlook** - Hospitals - Ambulatory Surgical Centers - Diagnostic Imaging Centers - Specialty Clinics ### **Coronary Angiography Devices Market Technology Outlook** - Digital Angiography - Computed Tomography Angiography - Magnetic Resonance Angiography ## Market Drivers ### Growing Geriatric Population The aging population in the US is a significant factor propelling the coronary angiography-devices market. As individuals age, the risk of developing cardiovascular diseases escalates, necessitating regular monitoring and intervention. The US Census Bureau projects that by 2030, all baby boomers will be over 65 years old, leading to a substantial increase in the demand for cardiovascular care. This demographic shift is likely to result in heightened utilization of coronary angiography devices, as healthcare providers seek to manage the health of older patients effectively. Consequently, the market is expected to expand as hospitals and clinics adapt to the needs of this growing population segment. ### Increased Healthcare Expenditure Rising healthcare expenditure in the US is another critical driver for the coronary angiography-devices market. According to the Centers for Medicare & Medicaid Services, national health spending is projected to reach $6.2 trillion by 2028, reflecting a growth rate of approximately 5.4% annually. This increase in spending facilitates the adoption of advanced medical technologies, including coronary angiography devices. As healthcare systems allocate more resources towards innovative diagnostic tools, the market is likely to experience robust growth. Enhanced funding for cardiovascular care initiatives further supports the expansion of this market, as healthcare providers invest in the latest angiography technologies to improve patient outcomes. ### Rising Incidence of Cardiovascular Diseases The increasing prevalence of cardiovascular diseases in the US is a primary driver for the coronary angiography-devices market. According to the American Heart Association, cardiovascular diseases account for approximately 697,000 deaths annually, representing about 1 in every 5 deaths. This alarming statistic underscores the urgent need for effective diagnostic tools, such as coronary angiography devices, to facilitate early detection and treatment. As healthcare providers strive to address this growing health crisis, investments in advanced angiography technologies are likely to surge. The market is projected to expand as hospitals and clinics adopt these devices. This adoption aims to improve patient outcomes and reduce mortality rates associated with heart diseases. ### Rising Awareness and Education on Heart Health The growing awareness and education regarding heart health among the US population are driving the coronary angiography-devices market. Public health campaigns and initiatives by organizations such as the American Heart Association have significantly increased knowledge about the importance of early detection and treatment of cardiovascular diseases. This heightened awareness encourages individuals to seek medical advice and undergo diagnostic procedures, including coronary angiography. As more patients become proactive about their heart health, the demand for angiography devices is expected to rise. This trend may lead to increased investments in the development and distribution of advanced coronary angiography technologies, further propelling market growth. ### Technological Innovations in Imaging Techniques Technological advancements in imaging techniques are significantly influencing the coronary angiography-devices market. Innovations such as 3D imaging, optical coherence tomography, and advanced fluoroscopy systems enhance the precision and effectiveness of coronary angiography procedures. These technologies allow for better visualization of coronary arteries, leading to improved diagnostic accuracy and treatment planning. The integration of artificial intelligence in image analysis further streamlines workflows and reduces procedural times. As a result, healthcare facilities are increasingly investing in state-of-the-art angiography devices, which is expected to drive market growth. The market is anticipated to witness a compound annual growth rate (CAGR) of around 6% over the next few years. ## Future Outlook The [Coronary Angiography Devices Market](https://www.marketresearchfuture.com/reports/coronary-angiography-devices-market-6151) is projected to grow at 11.42% CAGR from 2025 to 2035, driven by technological advancements, increasing cardiovascular diseases, and rising healthcare expenditures. **New opportunities:** - Development of AI-driven imaging software for enhanced diagnostic accuracy. - Expansion of telehealth services for remote patient monitoring and consultations. - Introduction of portable angiography devices for outpatient settings. By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs. ## Segment Insights ### By Type: Angiography Systems (Largest) vs. Angiography Catheters (Fastest-Growing) The market share distribution within the US coronary angiography-devices market reveals that Angiography Systems hold the largest share, underscoring their essential role in diagnostic procedures. Angiography Catheters and Contrast Media are also significant but take a secondary position in terms of overall revenue contribution. This distribution indicates a mature market where some segments are well-established, while others are rapidly gaining prominence among healthcare providers. Growth trends in the segment indicate a robust expansion, driven by advancements in technology and increasing demand for minimally invasive procedures. Angiography Catheters are witnessing the fastest growth, attributed to rising prevalence of cardiovascular diseases and the subsequent need for efficient diagnostic tools. The increasing adoption of innovative systems and materials is expected to bolster this segment's growth, making it an attractive focus for manufacturers. Angiography Systems (Dominant) vs. Angiography Catheters (Emerging) Angiography Systems are characterized by their comprehensive capabilities in performing diagnostic and therapeutic procedures, making them a dominant force in the segment. Their integration with advanced imaging techniques enhances accuracy and efficiency, leading to increased utilization in clinical practice. On the other hand, Angiography Catheters represent an emerging segment, known for their critical function in facilitating blood flow and delivering treatments. The fast-paced innovation in catheter design, including improvements in flexibility and guiding capabilities, allows for enhanced performance in complex cases, driving their rapid adoption in the healthcare sector. ### By Application: Coronary Angiography (Largest) vs. Interventional Angiography (Fastest-Growing) The market share distribution in the application segment of the US coronary angiography-devices market reveals that coronary angiography significantly leads, driven by its essential role in diagnosing heart diseases. Peripheral angiography and neuro angiography also hold notable portions of the market, but they lag behind coronary angiography in terms of share. Interventional angiography is witnessing an increasing share as a result of advancements in technology and improved procedures, which cater to a growing demand for minimally invasive solutions. In terms of growth trends, interventional angiography is emerging as a segment to watch due to its innovative approaches and enhanced patient outcomes. Factors propelling this growth include an aging population, increasing prevalence of cardiovascular diseases, and ongoing research leading to new device development. Additionally, industry collaboration and investments in healthcare infrastructure support the advancement of interventional angiography technologies, positioning it as a vital component of the overall market growth. Coronary Angiography (Dominant) vs. Interventional Angiography (Emerging) The coronary angiography segment is established as the dominant force in the US coronary angiography-devices market, largely due to its crucial role in the detection and management of coronary artery diseases. This application utilizes specialized catheters and contrast agents to visualize coronary arteries, making it indispensable in clinical practices. On the other hand, interventional angiography is rapidly emerging, characterized by cutting-edge techniques that allow for the treatment of vascular disorders with less invasive interventions. This segment is driven by technological advancements, significant research investments, and a shift towards outpatient procedures. Together, these segments embody the extensive capabilities of angiography devices, catering to diverse patient needs while shaping the future of cardiovascular care. ### By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing) In the US coronary angiography-devices market, hospitals dominate the end-user segment, capturing the largest share due to their comprehensive cardiac care services and advanced technological capabilities. Ambulatory surgical centers, while smaller in market share, are gaining traction due to their flexible scheduling and cost-effective procedures. The growth trends in this segment are driven by an increasing prevalence of cardiovascular diseases and the need for efficient healthcare delivery. Specialty clinics are also emerging as vital players by offering targeted treatments for specific conditions. The combination of technological advancements in angiography devices and the shift towards outpatient services further supports the growth of ambulatory surgical centers, positioning them as a key focus for future investments. Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging) Hospitals represent the dominant segment in the end-user classification, attributed to their expansive resources and capability to provide intricate diagnostic procedures and emergency care. They are equipped with advanced angiography devices that support a range of cardiovascular interventions, contributing to their market strength. Conversely, ambulatory surgical centers are emerging as vital alternatives, attracting patients with their lower costs and shorter wait times for procedures. These centers typically focus on outpatient services, which are becoming increasingly preferred due to regulatory changes and patient preferences for minimally invasive solutions. Their agility in adopting new technologies positions them strongly within the market, allowing them to grow rapidly as they fulfill a critical role in healthcare delivery. ### By Technology: Digital Angiography (Largest) vs. Computed Tomography Angiography (Fastest-Growing) In the US coronary angiography-devices market, Digital Angiography holds a significant share, being the most widely used technology for imaging procedures. This method boasts advanced imaging capabilities, enabling accurate visualization of vascular structures, which has led to its dominant position among clinicians and healthcare providers. Following closely, Computed Tomography Angiography has begun to capture greater attention due to its rapid imaging capabilities and improved patient outcomes, establishing itself as a formidable competitor in the market. Growth trends indicate that while Digital Angiography remains the frontrunner, Computed Tomography Angiography is gaining momentum as technology advances and the demand for efficient diagnostic solutions increases. Factors driving this growth include an aging population with rising cardiovascular diseases, increased adoption of minimally invasive procedures, and continuous innovations in imaging technologies. Magnetic Resonance Angiography, while less prevalent, is also seeing gradual acceptance among niche segments due to its non-invasive nature and ability to provide detailed imagery without ionizing radiation. Technology: Digital Angiography (Dominant) vs. Computed Tomography Angiography (Emerging) Digital Angiography is characterized by its high-resolution images and real-time feedback, making it preferred for complex interventions and diagnostic evaluations. Its established market presence stems from its long-standing reliability and efficacy in diagnosing cardiovascular conditions. Conversely, Computed Tomography Angiography is an emerging technology that leverages advanced imaging algorithms and rapid acquisition techniques, which appeal to healthcare settings requiring quick decision-making. This technology is increasingly being utilized for its ability to present comprehensive results in a short timeframe, positioning it favorably for growth in the current market dynamics. ## Competitive Benchmarking The coronary angiography-devices market is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of cardiovascular diseases. Major players such as Abbott (US), Boston Scientific (US), and Medtronic (US) are strategically positioned to leverage innovation and expand their market presence. Abbott (US) focuses on enhancing its product portfolio through continuous innovation, while Boston Scientific (US) emphasizes strategic partnerships to bolster its technological capabilities. Medtronic (US) is actively pursuing regional expansion and digital transformation initiatives, which collectively shape a competitive environment that is increasingly reliant on cutting-edge technology and strategic collaborations.Key business tactics within this market include localizing manufacturing and optimizing supply chains to enhance operational efficiency. The competitive structure appears moderately fragmented, with several key players exerting influence over market dynamics. This fragmentation allows for a diverse range of products and services, catering to varying customer needs while fostering competition among established and emerging companies. In October Abbott (US) announced the launch of its latest coronary imaging system, which integrates advanced AI algorithms to improve diagnostic accuracy. This strategic move is likely to enhance Abbott's competitive edge by positioning it as a leader in innovative imaging solutions, thereby attracting healthcare providers seeking state-of-the-art technology. In September Boston Scientific (US) entered into a partnership with a leading telehealth provider to enhance remote monitoring capabilities for patients undergoing coronary procedures. This collaboration underscores Boston Scientific's commitment to integrating digital health solutions, potentially improving patient outcomes and expanding its market reach in the growing telehealth sector. In August Medtronic (US) completed the acquisition of a startup specializing in AI-driven analytics for cardiovascular imaging. This acquisition is expected to bolster Medtronic's technological capabilities, allowing it to offer more comprehensive solutions in the coronary angiography space, thus enhancing its competitive positioning. As of November current trends in the coronary angiography-devices market include a pronounced shift towards digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, advanced technology, and reliable supply chains, reflecting the industry's response to changing market demands. ## Recent News & Developments Recent developments in the US Coronary Angiography Devices Market highlight significant growth and innovation. Abbott has launched new imaging technologies, enhancing procedural safety and effectiveness. Philips is advancing its integration of AI in cardiovascular imaging solutions. This allows for improved patient outcomes. Medtronic is focusing on expanding its product portfolio. This is particularly in catheter-based intervention devices. Boston Scientific is investing in clinical studies to validate efficacy of its latest offerings. In terms of mergers and acquisitions, Terumo acquired Merit Medical Systems in August 2023. This strengthened its presence in the US market. Additionally, GE Healthcare announced its acquisition of a medical data analytics firm in May 2023. This aimed to bolster its technological capabilities in cardiac imaging. The market is witnessing an uptick in investment. This is particularly in Research and Development initiatives. Leading companies like Johnson and Johnson and Stryker are increasing their allocation to drive innovation. Overall, the US Coronary Angiography Devices Market is evolving rapidly. This is driven by technological advancements, strategic partnerships, and ongoing emphasis. This emphasis is on enhancing patient care through improved diagnostic and treatment solutions. ## Report Scope | MARKET SIZE 2024 | 2871.64(USD Million) | | --- | --- | | MARKET SIZE 2025 | 3199.59(USD Million) | | MARKET SIZE 2035 | 9436.18(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 11.42% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Abbott (US), Boston Scientific (US), Medtronic (US), Siemens Healthineers (DE), Philips (NL), GE Healthcare (US), Cardinal Health (US), Terumo (JP), B. Braun (DE) | | Segments Covered | Type, Application, End User, Technology | | Key Market Opportunities | Integration of advanced imaging technologies enhances diagnostic accuracy in the coronary angiography-devices market. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation in the coronary angiography-devices market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What is the current market valuation of the US coronary angiography-devices market?** A: The market valuation was $2871.64 Million in 2024. **Q: What is the projected market size for the US coronary angiography-devices market by 2035?** A: The projected market size is $9436.18 Million by 2035. **Q: What is the expected CAGR for the US coronary angiography-devices market during the forecast period 2025 - 2035?** A: The expected CAGR is 11.42% during the forecast period 2025 - 2035. **Q: Which segment had the highest valuation in the US coronary angiography-devices market in 2024?** A: The Angiography Systems segment had the highest valuation at $1200.0 Million in 2024. **Q: What are the key players in the US coronary angiography-devices market?** A: Key players include Abbott, Boston Scientific, Medtronic, Siemens Healthineers, Philips, GE Healthcare, Cardinal Health, Terumo, and B. Braun. **Q: How does the valuation of Contrast Media compare to Angiography Catheters in 2024?** A: In 2024, Contrast Media was valued at $600.0 Million, while Angiography Catheters were valued at $500.0 Million. **Q: What is the valuation of the Peripheral Angiography segment in 2024?** A: The Peripheral Angiography segment was valued at $860.0 Million in 2024. **Q: Which end user segment is expected to dominate the US coronary angiography-devices market by 2035?** A: Hospitals are expected to dominate, with a projected valuation of $4785.45 Million by 2035. **Q: What technology segment is projected to have the highest growth in the US coronary angiography-devices market?** A: Digital Angiography is projected to have the highest growth, with a valuation of $3800.0 Million by 2035. **Q: What is the valuation of the Guidewires segment in 2024?** A: The Guidewires segment was valued at $271.64 Million in 2024. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-coronary-angiography-devices-market-56735*